Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAN021 in mild-to-moderate plaque psoriasis
NCT02993328Phase 2Withdrawn
- Sponsor
- Santalis Pharmaceuticals, Inc.
- Start
- Jun 2018
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of east indian sandalwood oil in plaque psoriasis, sponsored by Santalis Pharmaceuticals, Inc.. Planned start Jun 2018; status: withdrawn.
02
Drugs
east indian sandalwood oil
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT02993328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02993328.